According to FutureWise analysis the market for nasal packing devices in 2023 is US$ 0.19 billion, and is expected to reach US$ 0.29 billion by 2031 at a CAGR of 5.32%.
Nasal packing devices are intranasal devices that apply constant local pressure to the nasal septum and are used to treat epistaxis (nosebleed). Epistaxis is caused by a tiny blood artery in the nose lining rupturing. The inside of the nose is delicate and highly sensitive to certain conditions, making it vulnerable to burst and bleeding. There are two types of epistaxis: anterior and posterior, each of which necessitates a distinct nasal packing device. For failure of anterior packing, reliable or high suspicion of posterior bleeding, and patients with bleeding diathesis, such as antiplatelet medication, von Willebrand disease (vWD), anticoagulation, and hemophilia, posterior nasal packing is recommended. When no source can be found or cautery fails, anterior nasal packing is recommended.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Nasal Packing Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Nasal Packing Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.